Brief: Intra-Cellular Therapies Reports Second Quarter 2023 Financial Results

Intra-Cellular Therapies

03/08/2023 14:54

Aug 3 (Reuters) - Intra-Cellular Therapies Inc  ITCI.O :
    * INTRA-CELLULAR THERAPIES REPORTS SECOND QUARTER 2023
FINANCIAL
RESULTS AND RAISES 2023 CAPLYTA SALES GUIDANCE
    * INTRA-CELLULAR THERAPIES INC - 2023 CAPLYTA NET PRODUCT
SALES
GUIDANCE RAISED TO $445 - $465 MILLION
    * INTRA-CELLULAR THERAPIES INC - TOTAL REVENUES WERE $110.8
MILLION FOR Q2 OF 2023, COMPARED TO $55.6 MILLION FOR SAME
PERIOD IN 2022
    * INTRA-CELLULAR THERAPIES INC - CASH, CASH EQUIVALENTS,
RESTRICTED CASH AND INVESTMENT SECURITIES TOTALED $514.6 MILLION
AT JUNE 30, 2023
    * INTRA-CELLULAR THERAPIES INC - QTRLY NET LOSS PER SHARE
$0.45

Source text for Eikon:  ID:nGNX5hR1PR 
Further company coverage:  ITCI.O 

 ((Reuters.Briefs@thomsonreuters.com;))